[1] Powell R.J., Du Toit G.L., Siddique N., Leech S.C., Dixon T.A., Clark A.T., et al., BSACI guidelines for the management of chronic urticaria and angiooedema, Clin Exp Allergy, 2007, 37(5), 631–650 http://dx.doi.org/10.1111/j.1365-2222.2007.02678.x[Crossref]
[2] Sheikh J., Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they, Curr Opin Allergy Clin Immunol., 2005, 5(5), 403–407 http://dx.doi.org/10.1097/01.all.0000182540.45348.bc[Crossref]
[3] Grattan C. E., Autoimmune urticaria, Immunol Allergy Clin North Am., 2004, 24(2), 163–181 http://dx.doi.org/10.1016/j.iac.2004.01.003[Crossref]
[4] Irinyi B., Szeles G., Gyimesi E., Tumpek J., Heredi E., Dimitrios G., et al., Clinical and laboratory examinations in the subgroups of chronic urticaria, Int Arch Allergy Immunol., 2007, 144(3), 217–225 http://dx.doi.org/10.1159/000103995[Crossref][WoS]
[5] Sabroe R.A., Seed P.T., Francis D.M., Barr R.M., Black A.K., Greaves M.W., Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies, J Am Acad Dermatol., 1999, 40(3), 443–450 http://dx.doi.org/10.1016/S0190-9622(99)70495-0[Crossref]
[6] Zuberbier T., Bindslev-Jensen C., Canonica W., Grattan C.E., Greaves M.W., Henz B.M. et al., EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria, Allergy, 2006, 61(3), 316–320 http://dx.doi.org/10.1111/j.1398-9995.2005.00964.x[Crossref][WoS]
[7] Sabroe R.A., Grattan C.E., Francis D.M., Barr R.M., Kobza Black A., Greaves M.W., The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria, Br J Dermatol., 1999, 140(3), 446–452 http://dx.doi.org/10.1046/j.1365-2133.1999.02707.x[Crossref]
[8] Fiebiger E., Maurer D., Holub H., Reininger B., Hartmann G., Woisetschlager M., et al., Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients, J Clin Invest., 1995, 96(6), 2606–2612 http://dx.doi.org/10.1172/JCI118325[Crossref]
[10] Asero R., Lorini M., Chong S.U., Zuberbier T., Tedeschi A., Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells, Clin Exp Allergy, 2004, 34(7), 1111–1114 http://dx.doi.org/10.1111/j.1365-2222.2004.01997.x[Crossref]
[11] De Swerdt A., Van Den Keybus C., Kasran A., Cadot P., Neyens K., Coorevits L., et al., Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63, J Allergy Clin Immunol., 2005, 116(3), 662–667 http://dx.doi.org/10.1016/j.jaci.2005.04.042[Crossref]
[12] Frezzolini A., Provini A., Teofoli P., Pomponi D., De Pita O., Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria, Allergy, 2006 Sep, 61(9), 1071–1077 http://dx.doi.org/10.1111/j.1398-9995.2006.01033.x[Crossref]
[13] Gyimesi E., Sipka S., Danko K., Kiss E., Hidvegi B., Gal M., et al., Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria, Br J Dermatol, 2004 Aug; 151(2), 388–396 http://dx.doi.org/10.1111/j.1365-2133.2004.06042.x[Crossref]
[14] Szegedi A., Irinyi B., Gal M., Hunyadi J., Danko K., Kiss E., et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria, Br J Dermatol, 2006, 155(1), 67–75 http://dx.doi.org/10.1111/j.1365-2133.2006.07205.x[Crossref]
[15] Wedi B., Novacovic V., Koerner M., Kapp A., Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects ofanti-inflammatory drugs, J Allergy Clin Immunol, 2000, 105(3), 552–560 http://dx.doi.org/10.1067/mai.2000.104939[Crossref]
[16] Gentinetta T., Pecaric-Petkovic T., Wan D., Falcone F. H., Dahinden C. A., Pichler W. J., et al., Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria, J Allergy Clin Immunol, 2011, 128, 1227–1234 http://dx.doi.org/10.1016/j.jaci.2011.07.021[WoS][Crossref]
[17] Yasnowsky K.M., Dreskin S.C., Efaw B., Schoen D., Vedanthan P.K., Alam R. et al., Chronic urticaria sera increase basophil CD203c expression, J Allergy Clin Immunol, 2006, 117(6), 1430–1434 http://dx.doi.org/10.1016/j.jaci.2006.02.016[Crossref]
[18] Tedeschi A., Asero R., Cugno M., Basophil activation test and autologous serum skin test: Not overlapping tests in chronic urticaria, J Allergy Clin Immunol, 2012, 280–281 [Crossref][WoS]
[19] Confino-Cohen R., Chodick G., Shalev V., Leshno M., Kimhi O., Goldberg A., Chronic urticaria and autoimmunity: Association found in a large population study, J Allergy Clin Immunol, 2012, 129, 1307–1313 http://dx.doi.org/10.1016/j.jaci.2012.01.043[Crossref]
[20] Asero R., Tedeschi A., Lorini M., Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs, Ann Allergy Asthma Immunol, 2002, 88(5), 468–472 http://dx.doi.org/10.1016/S1081-1206(10)62384-8[Crossref]
[21] Erbagci Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J Dermatol, 2004, 31(5), 376–382 [Crossref]
[22] Boumiza R., Monneret G., Forissier M.F., Savoye J., Gutowski M.C., Powell W.S. et al., Marked improvement of the basophil activation test by detecting CD203c instead of CD63, Clin Exp Allergy, 2003, 33(2), 259–265 http://dx.doi.org/10.1046/j.1365-2222.2003.01594.x[Crossref]
[23] Eberlein-Konig B., Varga R., Mempel M., Darsow U., Behrendt H., Ring J., Comparison of basophil activation tests using CD63 or CD203c expression in patients with insect venom allergy, Allergy, 2006, 61(9), 1084–1085 http://dx.doi.org/10.1111/j.1398-9995.2006.01122.x[Crossref]
[24] Sudheer P.S., Hall J.E., Read G.F., Rowbottom A.W., Williams P.E., Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c, Anaesthesia, 2005, 60(3), 251–256 http://dx.doi.org/10.1111/j.1365-2044.2004.04086.x[Crossref]